speb/financial-data huggingface dataset:
Financial ratios for ATNM — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -7503000
Net income: -6878000
Capital expenditures: 0
Operating cash flow: -5392000
Depreciation & amortization: 204000
Net tangible assets: 19013000
Owner earnings: -6674000
Return on net tangible assets (%): -35.10229842739179
Buffett classification: The Gruesome
Stock price: 1.4
Shares outstanding: 31374994
Book value: 19013000
P/B ratio: 2.310260958291695
Market cap (USD): 43924991.599999994
Debt to equity: 0.06784831431126072
Current ratio: 7.340509983160933
Quick ratio: 7.340509983160933
Free cash flow (dilution-adjusted): -5589000
Buyback yield (%): 0
Retained earnings: -398642000
Capitalized R&D asset: 10038000
ROCI (R&D-adjusted, %): -10.529648908728626
Rule of 40 score: 0
Financial ratios for ATNM — quarterly report dated 2025-09-30
Total revenue: 90000
Operating income: -5692000
Net income: -5131000
Capital expenditures: 0
Operating cash flow: -6325000
Depreciation & amortization: 206000
Net tangible assets: 13784000
Owner earnings: -4925000
Return on net tangible assets (%): -35.72983168891468
Buffett classification: The Gruesome
Stock price: 1.6
Shares outstanding: 31374994
Book value: 13784000
P/B ratio: 3.6419029599535695
Market cap (USD): 50199990.400000006
Debt to equity: 0.0829222286709228
Current ratio: 7.955223880597015
Quick ratio: 7.955223880597015
COGS to revenue (%): 0
R&D to revenue (%): 4720
SG&A to revenue (%): 1704.4444444444443
Free cash flow (dilution-adjusted): -6434000
Buyback yield (%): 0
Retained earnings: -403773000
Capitalized R&D asset: 10057930
ROCI (R&D-adjusted, %): -11.878750846527314
FCF margin (%): -7148.88888888889
Rule of 40 score: -7148.88888888889
Financial ratios for ATNM — annual report dated 2025-12-31
Total revenue: 90000
Operating income: -36247000
Net income: -33887000
Capital expenditures: 104000
Operating cash flow: -24580000
Depreciation & amortization: 821000
Net tangible assets: 7834000
Owner earnings: -33170000
Return on net tangible assets (%): -423.41077355118716
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 31374994
Book value: 7834000
P/B ratio: 5.446769446004596
Market cap (USD): 42669991.84
Debt to equity: 0.21623691600714834
Current ratio: 6.196636968251976
Quick ratio: 6.196636968251976
COGS to revenue (%): 0
R&D to revenue (%): 23471.11111111111
SG&A to revenue (%): 16903.333333333332
Free cash flow (dilution-adjusted): -33874000
Buyback yield (%): 0
Retained earnings: -409713000
Capitalized R&D asset: 54015250
ROCI (R&D-adjusted, %): -46.07315213548521
FCF margin (%): -37637.77777777778
Rule of 40 score: -37637.77777777778
Financial ratios for ATNM — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -6414000
Net income: -5940000
Capital expenditures: 104000
Operating cash flow: -5289000
Depreciation & amortization: 206000
Net tangible assets: 7834000
Owner earnings: -5838000
Return on net tangible assets (%): -74.52131733469491
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 31374994
Book value: 7834000
P/B ratio: 5.446769446004596
Market cap (USD): 42669991.84
Debt to equity: 0.21623691600714834
Current ratio: 6.196636968251976
Quick ratio: 6.196636968251976
Free cash flow (dilution-adjusted): -5403000
Buyback yield (%): 0
Retained earnings: -409713000
Capitalized R&D asset: 8753230
ROCI (R&D-adjusted, %): -12.541406460229092
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for BOL.V — annual report dated 2021-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0813008130081301
Shares outstanding: 105423985
Market cap (USD): 8571055.691056913
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOL.V — annual report dated 2022-10-31
Total revenue: 0
Operating income: -178998.5294117647
Net income: -182675
Capital expenditures: 241313.23529411762
Operating cash flow: -222174.26470588235
Net tangible assets: 1038427.2058823529
Owner earnings: -423988.2352941176
Return on net tangible assets (%): -40.829846607673794
Buffett classification: The Gruesome
Stock price: 0.058823529411764705
Shares outstanding: 105423985
Book value: 1038427.2058823529
P/B ratio: 5.971926435694252
Market cap (USD): 6201410.882352941
Debt to equity: 0
Current ratio: 0.6896949496327356
Quick ratio: 0.6896949496327356
Free cash flow (dilution-adjusted): -463487.49999999994
Buyback yield (%): 0
Retained earnings: -8484984.55882353
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.237465312714857
Rule of 40 score: 0
Financial ratios for BOL.V — annual report dated 2023-10-31
Total revenue: 0
Operating income: -171696.3768115942
Net income: -151984.0579710145
Capital expenditures: 99692.02898550725
Operating cash flow: -59899.27536231885
Net tangible assets: 1011094.9275362319
Owner earnings: -251676.08695652173
Return on net tangible assets (%): -24.891439972880598
Buffett classification: The Gruesome
Stock price: 0.043478260869565216
Shares outstanding: 105423985
Book value: 1011094.9275362319
P/B ratio: 4.533354284457014
Market cap (USD): 4583651.52173913
Debt to equity: 0.02519366650158997
Current ratio: 0.1506889224880575
Quick ratio: 0.1506889224880575
Free cash flow (dilution-adjusted): -159591.3043478261
Buyback yield (%): 0
Retained earnings: -8383957.971014493
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.981232141078227
Rule of 40 score: 0
Financial ratios for BOL.V — annual report dated 2024-10-31
Total revenue: 0
Operating income: -133268.34532374103
Net income: -83422.30215827339
Capital expenditures: 11644.604316546764
Operating cash flow: -79620.1438848921
Net tangible assets: 1103933.09352518
Owner earnings: -95066.90647482016
Return on net tangible assets (%): -8.611654730926114
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 105423985
Book value: 1103933.09352518
P/B ratio: 3.4351988345138738
Market cap (USD): 3792229.6762589933
Debt to equity: 0.024733669736788085
Current ratio: 0.4594589458280676
Quick ratio: 0.4594589458280676
Free cash flow (dilution-adjusted): -79966.18705035972
Buyback yield (%): 0
Retained earnings: -8330804.316546763
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.072139707142613
Rule of 40 score: 0
Financial ratios for BOL.V — quarterly report dated 2024-10-31
Total revenue: 0
Operating income: -44627.338129496406
Net income: -19997.841726618706
Capital expenditures: 1970.5035971223024
Operating cash flow: -62567.62589928058
Net tangible assets: 1103933.09352518
Owner earnings: -21968.345323741007
Return on net tangible assets (%): -1.9900069535545566
Buffett classification: The Gruesome
Stock price: 0.03597122302158274
Shares outstanding: 105423985
Book value: 1103933.09352518
P/B ratio: 3.4351988345138738
Market cap (USD): 3792229.6762589933
Debt to equity: 0.024733669736788085
Current ratio: 0.4594589458280676
Quick ratio: 0.4594589458280676
Free cash flow (dilution-adjusted): -60597.12230215828
Buyback yield (%): 0
Retained earnings: -8330804.316546763
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.0425763473570955
Rule of 40 score: 0
Financial ratios for BOL.V — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -99275.86206896552
Net income: -98555.1724137931
Capital expenditures: 39128.965517241384
Operating cash flow: -28968.275862068967
Net tangible assets: 1041008.275862069
Owner earnings: -137684.1379310345
Return on net tangible assets (%): -13.22603682636595
Buffett classification: The Gruesome
Stock price: 0.034482758620689655
Shares outstanding: 105423985
Book value: 1041008.2758620689
P/B ratio: 3.4921046372813627
Market cap (USD): 3635309.827586207
Debt to equity: 0.02561111177359881
Current ratio: 0.23772811621261625
Quick ratio: 0.23772811621261625
Free cash flow (dilution-adjusted): -131821.37931034484
Buyback yield (%): 0
Retained earnings: -8084636.551724138
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.536510359320078
Rule of 40 score: 0
Financial ratios for BOL.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -82037.6811594203
Net income: -73146.37681159421
Capital expenditures: 0
Operating cash flow: -73146.37681159421
Net tangible assets: 1342322.463768116
Owner earnings: -73146.37681159421
Return on net tangible assets (%): -5.44924031191883
Buffett classification: The Gruesome
Stock price: 0.06521739130434782
Shares outstanding: 105423985
Book value: 1342322.4637681162
P/B ratio: 5.122075706986322
Market cap (USD): 6875477.282608695
Debt to equity: 0.02123833610900424
Current ratio: 0.9970355638702091
Quick ratio: 0.9970355638702091
Free cash flow (dilution-adjusted): -73146.37681159421
Buyback yield (%): 0
Retained earnings: -8567873.188405797
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.111622458371684
Rule of 40 score: 0
Financial ratios for BOL.V — quarterly report dated 2025-07-31
Capital expenditures: 109756.52173913045
Operating cash flow: -87508.69565217392
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 105423985
Market cap (USD): 5347593.442028986
Free cash flow (dilution-adjusted): -197265.21739130435
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BOL.V — annual report dated 2025-10-31
Total revenue: 0
Operating income: -399658.5714285715
Net income: -875953.5714285715
Capital expenditures: 334109.28571428574
Operating cash flow: -212230
Net tangible assets: 972902.8571428572
Owner earnings: -1210062.8571428573
Return on net tangible assets (%): -124.37653443597365
Buffett classification: The Gruesome
Stock price: 0.05000000000000001
Shares outstanding: 105423985
Book value: 972902.8571428572
P/B ratio: 5.418011892245887
Market cap (USD): 5271199.250000001
Debt to equity: 0.029920033126196715
Current ratio: 0.7041061767796676
Quick ratio: 0.7041061767796676
Free cash flow (dilution-adjusted): -612339.2857142858
Buyback yield (%): 0
Retained earnings: -9134802.142857144
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.07901029541219
Rule of 40 score: 0
Financial ratios for BOL.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -85636.42857142858
Net income: -571442.1428571428
Capital expenditures: 185394.28571428574
Operating cash flow: -23867.14285714286
Net tangible assets: 972902.8571428572
Owner earnings: -756836.4285714286
Return on net tangible assets (%): -77.79157220218728
Buffett classification: The Gruesome
Stock price: 0.05000000000000001
Shares outstanding: 105423985
Book value: 972902.8571428572
P/B ratio: 5.418011892245887
Market cap (USD): 5271199.250000001
Debt to equity: 0.029920033126196715
Current ratio: 0.7041061767796676
Quick ratio: 0.7041061767796676
Free cash flow (dilution-adjusted): -209261.42857142858
Buyback yield (%): 0
Retained earnings: -9134802.142857144
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.802162601876713
Rule of 40 score: 0
Financial ratios for BOL.V — quarterly report dated 2026-01-31
Total revenue: 0
Operating income: -210508.14814814815
Net income: -210507.4074074074
Capital expenditures: 187610.37037037036
Operating cash flow: -120461.48148148147
Net tangible assets: 1844197.7777777778
Owner earnings: -398117.77777777775
Return on net tangible assets (%): -21.58758580966852
Buffett classification: The Gruesome
Stock price: 0.08148148148148147
Shares outstanding: 105423985
Book value: 1844197.7777777778
P/B ratio: 4.657907402877573
Market cap (USD): 8590102.481481481
Debt to equity: 0.016652427814643482
Current ratio: 1.72420265607613
Quick ratio: 1.72420265607613
Free cash flow (dilution-adjusted): -308071.85185185185
Buyback yield (%): 0
Retained earnings: -9683635.555555554
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.414623487648544
Rule of 40 score: 0
Financial ratios for CANG — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.81
Shares outstanding: 39321967
Market cap (USD): 189138661.26999998
Buyback yield (%): 0
Capitalized R&D asset: 11025569.26
Rule of 40 score: 0
Financial ratios for CANG — annual report dated 2022-12-31
Total revenue: 287051361.88
Gross profit: 21794049.83
Operating income: -135060373.08
Net income: -161060960.24
Capital expenditures: 652077.6
Operating cash flow: -82238060.67
Depreciation & amortization: 2535069.35
Net tangible assets: 597877053.61
Owner earnings: -159177968.49
Return on net tangible assets (%): -26.623863138563113
Buffett classification: The Gruesome
Stock price: 6.55
Shares outstanding: 39321967
Book value: 626427174.5
P/B ratio: 0.41115534947151305
Market cap (USD): 257558883.85
Debt to equity: 0.2776999947501479
Current ratio: 2.161420410608658
Quick ratio: 2.161420410608658
Interest coverage ratio: -55.4350319965885
COGS to revenue (%): 92.407613157707
R&D to revenue (%): 2.3206221654453416
SG&A to revenue (%): 21.829589007905668
Free cash flow (dilution-adjusted): -105884626.7
Buyback yield (%): 5.955922226675701
Retained earnings: 1320363.95
Receivables turnover: 1.2072378170210707
Capitalized R&D asset: 14048508.9342
ROCI (R&D-adjusted, %): -20.220066849220423
FCF margin (%): -36.886996810091574
Rule of 40 score: -36.886996810091574
Financial ratios for CANG — annual report dated 2023-12-31
Total revenue: 0
Gross profit: 0
Operating income: -7023689
Net income: -5476743
Capital expenditures: 0
Operating cash flow: 146304470
Depreciation & amortization: 108960
Net tangible assets: 531642820.16
Owner earnings: -5367783
Return on net tangible assets (%): -1.0096596429882274
Buffett classification: The Gruesome
Stock price: 5.1
Shares outstanding: 39321967
Book value: 538466902.78
P/B ratio: 0.37243149145219595
Market cap (USD): 200542031.7
Debt to equity: 0.02372075786655836
Current ratio: 4.993963286576985
Quick ratio: 4.993963286576985
Effective tax rate (%): 0
Interest coverage ratio: -189829.43243243243
Free cash flow (dilution-adjusted): 142802037
Buyback yield (%): 17.038258119931076
Retained earnings: -47347258.41
Receivables turnover: 0
Capitalized R&D asset: 12349815.0409
ROCI (R&D-adjusted, %): -1.806379378705638
Rosenberg metric: -3.2717031472617943
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CANG — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.9
Shares outstanding: 39321967
Market cap (USD): 349965506.3
Buyback yield (%): 0
Capitalized R&D asset: 1424250
Rule of 40 score: 0
Financial ratios for CANG — quarterly report dated 2024-12-31
Total revenue: 90742927.86
Gross profit: 15771497.84
Operating income: 6070088.54
Net income: 6284151.33
Capital expenditures: 0
Net tangible assets: 553866898
Owner earnings: 6284151.33
Return on net tangible assets (%): 1.1345959386076183
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 22
P/E ratio: 34.41527855440744
Shares outstanding: 39321967
Book value: 553866898
P/B ratio: 1.561897410955222
Market cap (USD): 865083274
Debt to equity: 0.031141442217043274
Current ratio: 1.8407431511005357
Quick ratio: 1.8407431511005357
Effective tax rate (%): 0.26675398077752094
Interest coverage ratio: 67.21952580250858
COGS to revenue (%): 82.61958455392515
R&D to revenue (%): 0.16636670599048045
SG&A to revenue (%): 18.80892757431466
Buyback yield (%): 0
Retained earnings: -13585217
Receivables turnover: 1.030473386061495
Capitalized R&D asset: 1105213.52
ROCI (R&D-adjusted, %): 1.0143882108912845
Rule of 40 score: 0
Financial ratios for CANG — annual report dated 2024-12-31
Total revenue: 89908403
Gross profit: 14821291
Operating income: -1697267
Net income: 41652311
Capital expenditures: 128093706
Operating cash flow: -40831305
Depreciation & amortization: 11845686
Net tangible assets: 553866898
Owner earnings: -74595709
Return on net tangible assets (%): -13.468165234167866
Buffett classification: The Gruesome
Stock price: 22
P/E ratio: 20.76915429734499
Shares outstanding: 39321967
Book value: 553866898
P/B ratio: 1.561897410955222
Market cap (USD): 865083274
Debt to equity: 0.031141442217043274
Current ratio: 1.8407431511005357
Quick ratio: 1.8407431511005357
Effective tax rate (%): 0
Interest coverage ratio: -18.19618122561002
COGS to revenue (%): 83.51512149537346
R&D to revenue (%): 0.832957037397272
SG&A to revenue (%): 17.581598018151873
Free cash flow (dilution-adjusted): -170329019
Buyback yield (%): 1.4606013524658668
Retained earnings: -13585217
Receivables turnover: 1.0209965521250426
Capitalized R&D asset: 5793483.295700001
ROCI (R&D-adjusted, %): -0.8538472726198013
Rosenberg metric: 3.488795670571731
FCF margin (%): -189.44727446665914
Rule of 40 score: -189.44727446665914
Financial ratios for CANG — quarterly report dated 2025-03-31
Total revenue: 144154046
Gross profit: 10147500
Operating income: -170000
Net income: -32174926
Capital expenditures: 0
Net tangible assets: 525902987.97
Owner earnings: -32174926
Return on net tangible assets (%): -6.118034454262391
Buffett classification: The Gruesome
Stock price: 18.95
Shares outstanding: 39321967
Book value: 532409152.65000004
P/B ratio: 1.3995838932165283
Market cap (USD): 745151274.65
Debt to equity: 0.21560245006806045
Current ratio: 1.4062936426985528
Quick ratio: 1.4062936426985528
Interest coverage ratio: -0.12971187939542056
COGS to revenue (%): 92.96065543661535
R&D to revenue (%): 0.03103706156121348
SG&A to revenue (%): 6.956633738882362
Buyback yield (%): 0
Retained earnings: -33476452.13
Receivables turnover: 0.6873610295617106
Capitalized R&D asset: 615890.9134
ROCI (R&D-adjusted, %): -0.12332400592654626
Rosenberg metric: -37.2534020569662
Revenue growth (%): 58.85981354095576
Rule of 40 score: 58.85981354095576
Financial ratios for CANG — quarterly report dated 2025-06-30
Total revenue: 139659952.46
Gross profit: 1181714.37
Operating income: -2755314.31
Net income: -295000858.93
Capital expenditures: 0
Net tangible assets: 656053782.99
Owner earnings: -295000858.93
Return on net tangible assets (%): -44.965956538733444
Buffett classification: The Gruesome
Stock price: 24.25
Shares outstanding: 39321967
Book value: 656053782.99
P/B ratio: 1.4534748895191338
Market cap (USD): 953557699.75
Debt to equity: 0.34282557517609535
Current ratio: 1.6365309636849252
Quick ratio: 1.6365309636849252
Interest coverage ratio: -1.3432128064840636
COGS to revenue (%): 99.15386311595769
SG&A to revenue (%): 2.163646612199341
Buyback yield (%): 0
Retained earnings: -328901548.05
Receivables turnover: 0.3338087927800037
Capitalized R&D asset: 79795.3772
ROCI (R&D-adjusted, %): -0.42987436279965324
Rosenberg metric: -200.39224781286498
Revenue growth (%): -3.117563235096427
Rule of 40 score: -3.117563235096427
Financial ratios for CANG — quarterly report dated 2025-09-30
Total revenue: 224635729
Gross profit: 26706525
Operating income: 20240598
Net income: 37319940
Capital expenditures: 0
Net tangible assets: 688157998
Owner earnings: 37319940
Return on net tangible assets (%): 5.423164463460904
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 21.2
P/E ratio: 5.584318332237404
Shares outstanding: 39321967
Book value: 688455729
P/B ratio: 1.2108631903039913
Market cap (USD): 833625700.4
Debt to equity: 0.5918770442826833
Current ratio: 1.195713997061724
Quick ratio: 1.195713997061724
Effective tax rate (%): 4.114851477211748
Interest coverage ratio: 2.743895926993919
COGS to revenue (%): 88.11118555410212
SG&A to revenue (%): 2.668349343483111
Buyback yield (%): 0
Retained earnings: -343832432
Receivables turnover: 77.37468362714503
Capitalized R&D asset: 14764.5894
ROCI (R&D-adjusted, %): 1.8463232717825677
Revenue growth (%): 60.844769773452335
Rule of 40 score: 60.844769773452335
Financial ratios for CANG — quarterly report dated 2025-12-31
Total revenue: 179452863
Gross profit: -13911904
Operating income: -23797322
Net income: -291704828
Capital expenditures: 0
Net tangible assets: 396748450
Owner earnings: -291704828
Return on net tangible assets (%): -73.52387337619089
Buffett classification: The Gruesome
Stock price: 15
Shares outstanding: 39321967
Book value: 397041286
P/B ratio: 1.4855621463003221
Market cap (USD): 589829505
Debt to equity: 1.4099211385286516
Current ratio: 0.7080008039560505
Quick ratio: 0.7044420099618777
Interest coverage ratio: -2.5795612669759382
COGS to revenue (%): 107.75240013863696
SG&A to revenue (%): 5.510803134971439
Buyback yield (%): 0
Retained earnings: -635537260
Inventory turnover: 307.45820096229374
Receivables turnover: 67.40294637635597
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.4885718040504345
Revenue growth (%): -20.113837723472745
Rule of 40 score: -20.113837723472745
Financial ratios for CANG — annual report dated 2025-12-31
Total revenue: 688079223
Gross profit: 28142941
Operating income: -2432619
Net income: -621952043
Capital expenditures: 114778933
Operating cash flow: -109829414
Depreciation & amortization: 117007191
Net tangible assets: 396748450
Owner earnings: -619723785
Return on net tangible assets (%): -156.20068206945737
Buffett classification: The Gruesome
Stock price: 15
Shares outstanding: 39321967
Book value: 397041286
P/B ratio: 1.4855621463003221
Market cap (USD): 589829505
Debt to equity: 1.4099211385286516
Current ratio: 0.7080008039560505
Quick ratio: 0.7044420099618777
Interest coverage ratio: -0.12184091845477311
COGS to revenue (%): 95.90992722069156
SG&A to revenue (%): 4.199823949632614
Free cash flow (dilution-adjusted): -229489724
Buyback yield (%): 0.211893096124447
Retained earnings: -635537260
Inventory turnover: 1049.3267473772248
Receivables turnover: 258.44428556458126
Capitalized R&D asset: 1903685.8071
ROCI (R&D-adjusted, %): -0.4277263378428287
Rosenberg metric: 17.788328208005048
FCF margin (%): -33.35222403598139
Revenue growth (%): 665.3113613863211
Rule of 40 score: 631.9591373503397
Financial ratios for CCJ — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 21.6
Shares outstanding: 435532978
Market cap (USD): 9407512324.800001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCJ — annual report dated 2022-12-31
Total revenue: 1373531617.6470587
Gross profit: 171537500
Operating income: 11444852.94117647
Net income: 65722058.82352941
Capital expenditures: 104902941.17647058
Operating cash flow: 223975735.29411763
Depreciation & amortization: 130423529.4117647
Net tangible assets: 4256571323.5294113
Owner earnings: 91242647.05882353
Return on net tangible assets (%): 2.1435714363448763
Capex to operating income (%): 916.5949245101189
Buffett classification: The Gruesome
Stock price: 22.54
P/E ratio: 149.3701429907946
Shares outstanding: 435532978
Book value: 4291224264.705882
P/B ratio: 2.2876719366222273
Market cap (USD): 9816913324.119999
Debt to equity: 0.17083428645842702
Current ratio: 5.922598383499066
Quick ratio: 4.4558582557266675
Effective tax rate (%): -5.270357922047291
Interest coverage ratio: 0.22545554622092182
COGS to revenue (%): 87.51120849377651
R&D to revenue (%): 0.6517655485563995
SG&A to revenue (%): 9.20924645195966
Free cash flow (dilution-adjusted): 116059558.82352939
Buyback yield (%): 0
Retained earnings: 1982631617.6470587
Inventory turnover: 1.9872308560091807
Receivables turnover: 8.601174141265309
Capitalized R&D asset: 8952205.88235294
ROCI (R&D-adjusted, %): 0.2929403096545449
FCF margin (%): 8.44971876383496
Rule of 40 score: 8.44971876383496
Financial ratios for CCJ — annual report dated 2023-12-31
Total revenue: 1960422727.2727273
Gross profit: 425504545.45454544
Operating income: 215946212.12121212
Net income: 273368939.3939394
Capital expenditures: 116334848.48484848
Operating cash flow: 521315151.5151515
Depreciation & amortization: 166912121.21212122
Net tangible assets: 4583884848.484848
Owner earnings: 323946212.1212121
Return on net tangible assets (%): 7.0670669711148815
Capex to operating income (%): 53.87214128097274
Buffett classification: The Good
Stock price: 42.93
P/E ratio: 68.39632471411097
Shares outstanding: 435532978
Book value: 4616900757.575757
P/B ratio: 4.049779652477877
Market cap (USD): 18697430745.54
Debt to equity: 0.2927606722927899
Current ratio: 1.5489730082482271
Quick ratio: 0.8412022833999381
Effective tax rate (%): 25.933741555527735
Interest coverage ratio: 3.096843935031778
COGS to revenue (%): 78.29526563148485
R&D to revenue (%): 0.8129044524256132
SG&A to revenue (%): 9.488483853590637
Free cash flow (dilution-adjusted): 402131060.6060606
Buyback yield (%): 0
Retained earnings: 2257381060.6060605
Inventory turnover: 2.407391520805881
Receivables turnover: 5.969893971411962
Capitalized R&D asset: 21934341.577540107
ROCI (R&D-adjusted, %): 3.3637700048489623
Rosenberg metric: 28.36921411237633
FCF margin (%): 20.512466776259604
Revenue growth (%): 42.728620301515
Rule of 40 score: 63.24108707777461
Financial ratios for CCJ — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.57
Shares outstanding: 435532978
Market cap (USD): 20718303763.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCJ — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.29
Shares outstanding: 435532978
Market cap (USD): 22338486441.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCJ — annual report dated 2024-12-31
Total revenue: 2192847552.4475527
Gross profit: 547260139.8601398
Operating income: 357451748.25174826
Net income: 120176923.07692309
Capital expenditures: 147732867.13286713
Operating cash flow: 633068531.4685315
Depreciation & amortization: 196295104.89510491
Net tangible assets: 4422716783.216784
Owner earnings: 168739160.8391609
Return on net tangible assets (%): 3.8152829835156545
Capex to operating income (%): 41.329457152024034
Buffett classification: The Good
Stock price: 51.29
P/E ratio: 185.87999983425715
Shares outstanding: 435532978
Book value: 4450582517.482517
P/B ratio: 5.019227562655286
Market cap (USD): 22338486441.62
Debt to equity: 0.20132353225389057
Current ratio: 1.6219010407662253
Quick ratio: 0.8019609347920872
Effective tax rate (%): 33.061437541875065
Interest coverage ratio: 3.988296245435536
COGS to revenue (%): 75.04340239022478
R&D to revenue (%): 1.1652632908259912
SG&A to revenue (%): 8.072972142107272
Free cash flow (dilution-adjusted): 480334265.7342658
Buyback yield (%): 0
Retained earnings: 2167317482.5174828
Inventory turnover: 2.420347378717268
Receivables turnover: 8.947282521856241
Capitalized R&D asset: 39184039.12998766
ROCI (R&D-adjusted, %): 5.965999691155816
Rosenberg metric: 7.640111457282023
FCF margin (%): 21.90459000207923
Revenue growth (%): 11.855852410881141
Rule of 40 score: 33.76044241296037
Financial ratios for CCJ — quarterly report dated 2025-03-31
Total revenue: 552050349.6503496
Gross profit: 188906993.00699303
Operating income: 131488111.88811189
Net income: 48786013.986013986
Capital expenditures: 39465034.96503497
Operating cash flow: 77056643.35664336
Depreciation & amortization: 42379020.97902098
Net tangible assets: 4512348951.048951
Owner earnings: 51699999.99999999
Return on net tangible assets (%): 1.145744723221853
Capex to operating income (%): 30.014146829195653
Buffett classification: The Good
Stock price: 41.08
P/E ratio: 91.68454888202798
Shares outstanding: 435532978
Book value: 4539727272.727272
P/B ratio: 3.941138676705449
Market cap (USD): 17891694736.239998
Debt to equity: 0.15338464927346923
Current ratio: 2.7050481007636615
Quick ratio: 0.98621081388115
Effective tax rate (%): 43.36334922091314
Interest coverage ratio: 7.381462725238488
COGS to revenue (%): 65.78083989501313
R&D to revenue (%): 1.7711468498870075
SG&A to revenue (%): 7.4509267422653265
Free cash flow (dilution-adjusted): 36129370.62937063
Buyback yield (%): 0
Retained earnings: 2216083216.783217
Inventory turnover: 0.5447872287971028
Receivables turnover: 4.256868465184498
Capitalized R&D asset: 9777622.377622377
ROCI (R&D-adjusted, %): 2.2315298116692537
FCF margin (%): 6.544578887098574
Rule of 40 score: 6.544578887098574
Financial ratios for CCJ — quarterly report dated 2025-06-30
Total revenue: 640157664.2335765
Gross profit: 187656934.30656934
Operating income: 121141605.83941604
Net income: 234224817.51824817
Capital expenditures: 54647445.25547445
Operating cash flow: 339562043.7956204
Depreciation & amortization: 63118248.17518248
Net tangible assets: 4893181021.89781
Owner earnings: 242695620.4379562
Return on net tangible assets (%): 4.9598741463242915
Capex to operating income (%): 45.11038538478224
Buffett classification: The Good
Stock price: 74.09
P/E ratio: 114.01909308030861
Shares outstanding: 435532978
Book value: 4920790510.948905
P/B ratio: 6.55761269824865
Market cap (USD): 32268638340.02
Debt to equity: 0.14773678135804835
Current ratio: 2.9594018006418197
Quick ratio: 1.7536714107874276
Effective tax rate (%): 18.13531647830191
Interest coverage ratio: 7.413078434875826
COGS to revenue (%): 70.68582557216745
R&D to revenue (%): -0.0807282877393343
SG&A to revenue (%): 10.995922537331133
Free cash flow (dilution-adjusted): 283134306.5693431
Buyback yield (%): 0
Retained earnings: 2547363503.649635
Inventory turnover: 0.8443994649682223
Receivables turnover: 2.4950100708945455
Capitalized R&D asset: 6034218.67183911
ROCI (R&D-adjusted, %): 1.7929869831950922
Rosenberg metric: -0.12784894447188339
FCF margin (%): 44.22883961067986
Revenue growth (%): 15.960014270261974
Rule of 40 score: 60.188853880941835
Financial ratios for CCJ — quarterly report dated 2025-09-30
Total revenue: 442125899.2805756
Gross profit: 122482014.38848922
Operating income: 59360431.654676266
Net income: -101438.84892086331
Capital expenditures: 66530935.25179856
Operating cash flow: 112025899.28057554
Depreciation & amortization: 42523741.00719425
Net tangible assets: 4851410071.942447
Owner earnings: -24108633.09352518
Return on net tangible assets (%): -0.4969407396203135
Capex to operating income (%): 112.07960150767775
Buffett classification: The Gruesome
Stock price: 83.7
P/E ratio: 128.85436540811773
Shares outstanding: 435532978
Book value: 4878086330.935252
P/B ratio: 7.473035076771761
Market cap (USD): 36454110258.6
Debt to equity: 0.14691396260474832
Current ratio: 2.9905186175267002
Quick ratio: 1.565291203709569
Effective tax rate (%): 101.00579285759754
Interest coverage ratio: 6.354331921447825
COGS to revenue (%): 72.29702793077918
R&D to revenue (%): 1.6730805216782874
SG&A to revenue (%): 10.983394488695073
Free cash flow (dilution-adjusted): 43712230.215827346
Buyback yield (%): 0
Retained earnings: 2510608633.0935254
Inventory turnover: 0.4936958099109179
Receivables turnover: 2.92995437403754
Capitalized R&D asset: 10277489.511591176
ROCI (R&D-adjusted, %): 0.9326147653543662
FCF margin (%): 9.88682868091546
Revenue growth (%): -30.934842464175265
Rule of 40 score: -21.048013783259805
Financial ratios for CCJ — quarterly report dated 2025-12-31
Total revenue: 876591240.8759123
Gross profit: 199121897.81021896
Operating income: 149140145.98540145
Net income: 145303649.6350365
Capital expenditures: 79562043.79562043
Operating cash flow: 494397810.21897805
Depreciation & amortization: 63439416.05839416
Net tangible assets: 5012555474.452555
Owner earnings: 129181021.89781024
Return on net tangible assets (%): 2.577148972339677
Capex to operating income (%): 53.34716770587602
Buffett classification: The Good
Stock price: 91.49
P/E ratio: 93.05394329909083
Shares outstanding: 435532978
Book value: 5038962043.79562
P/B ratio: 7.907761918207492
Market cap (USD): 39846912157.22
Debt to equity: 0.14432760309518036
Current ratio: 2.466127383464183
Quick ratio: 1.519256465698486
Effective tax rate (%): 19.219640864360354
Interest coverage ratio: 3.753297329071605
COGS to revenue (%): 77.28452116276553
R&D to revenue (%): 1.2416210769986593
SG&A to revenue (%): 7.36887245717902
Free cash flow (dilution-adjusted): 412724087.5912409
Buyback yield (%): 0
Retained earnings: 2634144525.547445
Inventory turnover: 0.9159255443449702
Receivables turnover: 2.9189595162168467
Capitalized R&D asset: 15669473.402300056
ROCI (R&D-adjusted, %): 2.2817531035205034
Rosenberg metric: 10.360770079381865
FCF margin (%): 47.082844129133264
Revenue growth (%): 98.26733568476669
Rule of 40 score: 145.35017981389996
Financial ratios for CCJ — annual report dated 2025-12-31
Total revenue: 2541556934.306569
Gross profit: 708228467.1532847
Operating income: 453473722.62773716
Net income: 430348175.1824817
Capital expenditures: 242905109.48905107
Operating cash flow: 1028052554.7445254
Depreciation & amortization: 213937226.27737224
Net tangible assets: 5012555474.452555
Owner earnings: 401380291.9708028
Return on net tangible assets (%): 8.007498251471011
Capex to operating income (%): 53.56542118504522
Buffett classification: The Good
Stock price: 91.49
P/E ratio: 92.59226471757107
Shares outstanding: 435532978
Book value: 5038962043.79562
P/B ratio: 7.907761918207492
Market cap (USD): 39846912157.22
Debt to equity: 0.14432760309518036
Current ratio: 2.466127383464183
Quick ratio: 1.519256465698486
Effective tax rate (%): 24.151346844882223
Interest coverage ratio: 6.490445992958555
COGS to revenue (%): 72.13407035689659
R&D to revenue (%): 1.1047599135307888
SG&A to revenue (%): 8.939000262210675
Free cash flow (dilution-adjusted): 777920437.9562043
Buyback yield (%): 0
Retained earnings: 2634144525.547445
Inventory turnover: 2.4786248874994077
Receivables turnover: 8.463125631951465
Capitalized R&D asset: 50457242.04992089
ROCI (R&D-adjusted, %): 6.752065500047577
Rosenberg metric: 6.299526765987879
FCF margin (%): 30.608027207875626
Revenue growth (%): 15.90212604929164
Rule of 40 score: 46.51015325716727
Financial ratios for DBGI — annual report dated 2021-12-31
Capital expenditures: 43179
Buffett classification: The Gruesome
Stock price: 287500
Shares outstanding: 574638
Market cap (USD): 165208425000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBGI — annual report dated 2022-12-31
Total revenue: 10333558
Gross profit: 3544244
Operating income: -15153991
Net income: -38043362
Capital expenditures: 61286
Operating cash flow: -10767706
Depreciation & amortization: 1653819
Net tangible assets: -29332913
Owner earnings: -36450829
Buffett classification: The Gruesome
Stock price: 5275
Shares outstanding: 574638
Book value: -7453174
Market cap (USD): 3031215450
Debt to equity: -1.8520670522384155
Current ratio: 0.21591035666025682
Quick ratio: 0.09064527668760278
Interest coverage ratio: -1.691027528034093
COGS to revenue (%): 65.70161022950663
SG&A to revenue (%): 180.94672715825467
Free cash flow (dilution-adjusted): -11431030
Buyback yield (%): 0
Retained earnings: -103747316
Inventory turnover: 1.325374168092385
Receivables turnover: 7.262995794114008
Capitalized R&D asset: 0
FCF margin (%): -110.6204658647099
Rule of 40 score: -110.6204658647099
Financial ratios for DBGI — annual report dated 2023-12-31
Total revenue: 14916422
Gross profit: 6543780
Operating income: -12793787
Net income: -10247133
Capital expenditures: 29675
Operating cash flow: -6012644
Depreciation & amortization: 3249194
Net tangible assets: -17353126
Owner earnings: -7027614
Buffett classification: The Gruesome
Stock price: 163.5
Shares outstanding: 574638
Book value: 1602592
P/B ratio: 58.625846753259715
Market cap (USD): 93953313
Debt to equity: 5.410764561410515
Current ratio: 0.239482641850733
Quick ratio: 0.030586885683287827
Interest coverage ratio: -2.3189257507271006
COGS to revenue (%): 56.130364238823496
SG&A to revenue (%): 129.63944704701973
Free cash flow (dilution-adjusted): -6451129
Buyback yield (%): 0
Retained earnings: -113994449
Inventory turnover: 1.7264603266248764
Receivables turnover: 36.14840395110555
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -603.3023739216627
FCF margin (%): -43.24850155084108
Revenue growth (%): 44.34933253386684
Rule of 40 score: 1.1008309830257659
Financial ratios for DBGI — quarterly report dated 2024-09-30
Capital expenditures: 1
Buffett classification: The Gruesome
Stock price: 16.8
Shares outstanding: 574638
Market cap (USD): 9653918.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBGI — annual report dated 2024-12-31
Total revenue: 11555656
Gross profit: 3644120
Operating income: -8812782
Net income: -13106589
Capital expenditures: 0
Operating cash flow: -6152338
Depreciation & amortization: 2505598
Net tangible assets: -16422081
Owner earnings: -10600991
Buffett classification: The Gruesome
Stock price: 1.78
Shares outstanding: 574638
Book value: -1328541
Market cap (USD): 1022855.64
Debt to equity: -4.92880234783872
Current ratio: 0.22561453049820945
Quick ratio: 0.04194678758444214
Interest coverage ratio: -2.9963514532137028
COGS to revenue (%): 68.46462026906997
SG&A to revenue (%): 107.79917643792788
Free cash flow (dilution-adjusted): -6321952
Buyback yield (%): 0
Retained earnings: -127101038
Inventory turnover: 2.068948780577101
Receivables turnover: 26.61042295620295
Capitalized R&D asset: 0
FCF margin (%): -54.70872445493359
Revenue growth (%): -22.530644413251384
Rule of 40 score: -77.23936886818497
Financial ratios for DBGI — quarterly report dated 2024-12-31
Capital expenditures: 23801
Buffett classification: The Gruesome
Stock price: 1.78
Shares outstanding: 574638
Market cap (USD): 1022855.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DBGI — quarterly report dated 2025-03-31
Total revenue: 1871701
Gross profit: 872455
Operating income: -1996560
Net income: -2089910
Capital expenditures: 0
Operating cash flow: -4507347
Depreciation & amortization: 418225
Net tangible assets: -8453018
Owner earnings: -1671685
Buffett classification: The Gruesome
Stock price: 8.56
Shares outstanding: 574638
Book value: 6223982
P/B ratio: 0.7903141879266361
Market cap (USD): 4918901.28
Debt to equity: 1.0449684783792754
Current ratio: 0.6333358544377626
Quick ratio: 0.4172759180498497
Interest coverage ratio: -14.7977735449108
COGS to revenue (%): 53.387052739727125
SG&A to revenue (%): 153.28383112473628
Free cash flow (dilution-adjusted): -4507347
Buyback yield (%): 0
Retained earnings: -129190948
Inventory turnover: 0.2349176063016709
Receivables turnover: 5.254605532815649
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.422570827632214
FCF margin (%): -240.8155469276343
Rule of 40 score: -240.8155469276343
Financial ratios for DBGI — quarterly report dated 2025-06-30
Total revenue: 2251379
Gross profit: 711552
Operating income: -1985217
Net income: -2117862
Capital expenditures: 0
Operating cash flow: -1576928
Depreciation & amortization: 418225
Net tangible assets: -10154340
Owner earnings: -1699637
Buffett classification: The Gruesome
Stock price: 8.95
Shares outstanding: 574638
Book value: 7106120
P/B ratio: 0.7237437729731555
Market cap (USD): 5143010.1
Debt to equity: 0.9009709940164253
Current ratio: 0.33281938255531635
Quick ratio: 0.1225563131588563
Interest coverage ratio: -15.598467824310521
COGS to revenue (%): 68.39483711982744
SG&A to revenue (%): 119.78298633859514
Free cash flow (dilution-adjusted): -1576928
Buyback yield (%): 0
Retained earnings: -131308810
Inventory turnover: 0.37784439601167424
Receivables turnover: 4.440029266522569
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.525974399190368
FCF margin (%): -70.0427604592563
Revenue growth (%): 20.285184439181258
Rule of 40 score: -49.75757602007504
Financial ratios for DBGI — quarterly report dated 2025-09-30
Total revenue: 1653776
Gross profit: 706609
Operating income: -3329204
Net income: -3451950
Capital expenditures: 0
Operating cash flow: -5069268
Depreciation & amortization: 418213
Net tangible assets: -855052
Owner earnings: -3033737
Buffett classification: The Gruesome
Stock price: 8.2
Shares outstanding: 574638
Book value: 15988868
P/B ratio: 0.29470701740736116
Market cap (USD): 4712031.6
Debt to equity: 0.4000343238808401
Current ratio: 0.8062565331701325
Quick ratio: 0.6321527165188976
Interest coverage ratio: -25.895103644071092
COGS to revenue (%): 57.27299223111232
SG&A to revenue (%): 244.0362540029605
Free cash flow (dilution-adjusted): -5069268
Buyback yield (%): 0
Retained earnings: -134760760
Inventory turnover: 0.21930218170670832
Receivables turnover: 5.958372214516042
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -20.315064970663034
FCF margin (%): -306.52688151236924
Revenue growth (%): -26.54386489347196
Rule of 40 score: -333.0707464058412
Financial ratios for DBGI — annual report dated 2025-12-31
Total revenue: 7380921
Gross profit: 1054621
Operating income: -23859773
Net income: -28252558
Capital expenditures: 0
Operating cash flow: -15877168
Depreciation & amortization: 2092849
Net tangible assets: -1515312
Owner earnings: -26159709
Buffett classification: The Gruesome
Stock price: 12.68
Shares outstanding: 574638
Book value: 8768004
P/B ratio: 0.8310226409568243
Market cap (USD): 7286409.84
Debt to equity: 0.6985340107052871
Current ratio: 0.7908961733418597
Quick ratio: 0.6705640421431385
Interest coverage ratio: -46.36711013167918
COGS to revenue (%): 85.71152570255121
SG&A to revenue (%): 337.55128933096563
Free cash flow (dilution-adjusted): -15877168
Buyback yield (%): 0
Retained earnings: -155353596
Inventory turnover: 2.0168905778758295
Receivables turnover: 17.26854382106593
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -129.51294905690497
FCF margin (%): -215.11093263293293
Revenue growth (%): -36.127200394335034
Rule of 40 score: -251.23813302726796
Financial ratios for DBGI — quarterly report dated 2025-12-31
Total revenue: 1604065
Gross profit: -1235995
Operating income: -16548792
Net income: -20592836
Capital expenditures: 0
Operating cash flow: -4723625
Depreciation & amortization: 838186
Net tangible assets: -1515312
Owner earnings: -19754650
Buffett classification: The Gruesome
Stock price: 12.68
Shares outstanding: 574638
Book value: 8768004
P/B ratio: 0.8310226409568243
Market cap (USD): 7286409.84
Debt to equity: 0.6985340107052871
Current ratio: 0.7908961733418597
Quick ratio: 0.6705640421431385
Interest coverage ratio: -133.6455348634374
COGS to revenue (%): 177.05392237845723
SG&A to revenue (%): 954.6244697066517
Free cash flow (dilution-adjusted): -4723625
Buyback yield (%): 0
Retained earnings: -155353596
Inventory turnover: 0.9054408192153437
Receivables turnover: 3.752901127696411
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -89.82830034675169
FCF margin (%): -294.47840330659915
Revenue growth (%): -3.0059089018101606
Rule of 40 score: -297.48431220840934
Financial ratios for ERD.TO — annual report dated 2021-12-31
Gross profit: -29409.448818897636
Capital expenditures: 0
Depreciation & amortization: 29409.448818897636
Buffett classification: The Gruesome
Stock price: 2.031496062992126
Shares outstanding: 65493042
Market cap (USD): 133048856.97637795
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERD.TO — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -28006.61764705882
Operating income: -4424750
Net income: -4401644.852941176
Capital expenditures: 5861731.617647058
Operating cash flow: -3777472.7941176468
Depreciation & amortization: 100426.47058823529
Net tangible assets: 37959084.558823526
Owner earnings: -10162950
Return on net tangible assets (%): -26.7734328109281
Buffett classification: The Gruesome
Stock price: 1.2352941176470587
Shares outstanding: 65493042
Book value: 37959084.558823526
P/B ratio: 2.1313256225671005
Market cap (USD): 80903169.52941175
Debt to equity: 0.001600058731968661
Current ratio: 9.999099394969479
Quick ratio: 9.999099394969479
Interest coverage ratio: -544.8804780876494
Free cash flow (dilution-adjusted): -10596478.676470587
Buyback yield (%): 0
Retained earnings: -94874944.85294117
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.651452413916353
Rule of 40 score: 0
Financial ratios for ERD.TO — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -27998.484848484848
Operating income: -3018746.212121212
Net income: 395487.1212121212
Capital expenditures: 790363.6363636364
Operating cash flow: -1550405.303030303
Depreciation & amortization: 27999.242424242424
Net tangible assets: 44603632.57575757
Owner earnings: -366877.2727272727
Return on net tangible assets (%): -0.8225277887493707
Buffett classification: The Gruesome
Stock price: 1.6363636363636365
P/E ratio: 270.98336864970895
Shares outstanding: 65493042
Book value: 44603632.57575757
P/B ratio: 2.402728795274947
Market cap (USD): 107170432.36363637
Debt to equity: 0.00038961020211782934
Current ratio: 31.221819920387215
Quick ratio: 31.221819920387215
Interest coverage ratio: -1648.632602399669
Free cash flow (dilution-adjusted): -3529855.3030303027
Buyback yield (%): 0
Retained earnings: -97354456.06060606
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.767938030594227
Rule of 40 score: 0
Financial ratios for ERD.TO — quarterly report dated 2024-09-30
Gross profit: -4695.555555555556
Capital expenditures: 41788.88888888888
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 65493042
Market cap (USD): 183380517.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ERD.TO — quarterly report dated 2024-12-31
Total revenue: 0
Gross profit: -944.7552447552448
Operating income: -732392.3076923077
Net income: -1406376.9230769232
Capital expenditures: 54706.99300699301
Operating cash flow: -391902.0979020979
Depreciation & amortization: 1958.0419580419582
Net tangible assets: 43508644.755244754
Owner earnings: -1459125.8741258744
Return on net tangible assets (%): -3.3536458842469092
Buffett classification: The Gruesome
Stock price: 2.3496503496503496
Shares outstanding: 65493042
Book value: 43508644.75524476
P/B ratio: 3.536900537827367
Market cap (USD): 153885749.03496504
Debt to equity: 0
Current ratio: 9.43129280029022
Quick ratio: 9.43129280029022
Free cash flow (dilution-adjusted): -505996.5034965035
Buyback yield (%): 0
Retained earnings: -95632005.59440559
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6833259500780504
Rule of 40 score: 0
Financial ratios for ERD.TO — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -17902.097902097903
Operating income: -3776610.4895104896
Net income: -5766353.846153846
Capital expenditures: 243976.9230769231
Operating cash flow: -2305133.5664335666
Depreciation & amortization: 20858.74125874126
Net tangible assets: 43508644.755244754
Owner earnings: -5989472.027972028
Return on net tangible assets (%): -13.766165463588765
Buffett classification: The Gruesome
Stock price: 2.3496503496503496
Shares outstanding: 65493042
Book value: 43508644.75524476
P/B ratio: 3.536900537827367
Market cap (USD): 153885749.03496504
Debt to equity: 0
Current ratio: 9.43129280029022
Quick ratio: 9.43129280029022
Interest coverage ratio: -12647.665105386417
Free cash flow (dilution-adjusted): -3667976.223776224
Buyback yield (%): 0
Retained earnings: -95632005.59440559
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.680138190365575
Rule of 40 score: 0
Financial ratios for ERD.TO — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1730769.2307692308
Net income: -3147552.4475524477
Capital expenditures: 83216.78321678322
Operating cash flow: -974125.8741258741
Depreciation & amortization: 2097.902097902098
Net tangible assets: 43133404.8951049
Owner earnings: -3228671.3286713287
Return on net tangible assets (%): -7.485315236585328
Buffett classification: The Gruesome
Stock price: 3.1888111888111887
Shares outstanding: 65493042
Book value: 43133404.8951049
P/B ratio: 4.841837680720225
Market cap (USD): 208844945.1188811
Debt to equity: 0
Current ratio: 6.528482772632404
Quick ratio: 6.528482772632404
Free cash flow (dilution-adjusted): -1709790.2097902098
Buyback yield (%): 0
Retained earnings: -98779460.83916084
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.012595887058412
Rule of 40 score: 0